Phibro Animal Health (PAHC) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Phibro Animal Health Revenue Highlights

Latest Revenue (Y)

$1.52B

Latest Revenue (Q)

$373.91M

Main Segment (Y)

Vaccines

Main Geography (Y)

UNITED STATES

Phibro Animal Health Revenue by Period

Phibro Animal Health Revenue by Year

Date	Revenue	Change
2026-06-30	$1.52B	17.12%
2025-06-30	$1.30B	27.37%
2024-06-30	$1.02B	4.07%
2023-06-30	$977.89M	3.78%
2022-06-30	$942.26M	13.07%
2021-06-30	$833.35M	4.12%
2020-06-30	$800.35M	-3.34%
2019-06-30	$828.00M	0.98%
2018-06-30	$820.00M	7.29%
2017-06-30	$764.30M	1.70%
2016-06-30	$751.50M	0.39%
2015-06-30	$748.59M	8.19%
2014-06-30	$691.90M	5.93%
2013-06-30	$653.15M	-0.15%
2012-06-30	$654.10M	5.78%
2011-06-30	$618.33M	4.06%
2010-06-30	$594.20M	10.63%
2009-06-30	$537.10M	5.03%
2008-06-30	$511.40M	12.89%
2007-06-30	$453.00M	13.70%
2006-06-30	$398.40M	9.33%
2005-06-30	$364.40M	2.82%
2004-06-30	$354.40M	4.91%
2003-06-30	$337.80M	2.77%
2002-06-30	$328.70M	2.82%
2001-06-30	$319.70M	-1.02%
2000-06-30	$323.00M	-

Phibro Animal Health generated $1.52B in revenue during NA 2026, up 17.12% compared to the previous quarter, and up 182.17% compared to the same period a year ago.

Phibro Animal Health Revenue by Quarter

Date	Revenue	Change
2025-12-31	$373.91M	2.75%
2025-09-30	$363.89M	-3.91%
2025-06-30	$378.70M	8.88%
2025-03-31	$347.82M	12.47%
2024-12-31	$309.26M	18.75%
2024-09-30	$260.43M	-4.66%
2024-06-30	$273.16M	3.78%
2024-03-31	$263.22M	5.31%
2023-12-31	$249.94M	8.04%
2023-09-30	$231.35M	-9.29%
2023-06-30	$255.05M	3.82%
2023-03-31	$245.67M	0.42%
2022-12-31	$244.65M	5.21%
2022-09-30	$232.52M	-8.91%
2022-06-30	$255.26M	6.53%
2022-03-31	$239.62M	2.97%
2021-12-31	$232.71M	8.41%
2021-09-30	$214.66M	-2.55%
2021-06-30	$220.28M	4.04%
2021-03-31	$211.73M	2.71%
2020-12-31	$206.15M	5.61%
2020-09-30	$195.19M	5.01%
2020-06-30	$185.88M	-11.79%
2020-03-31	$210.74M	-1.53%
2019-12-31	$214.01M	12.80%
2019-09-30	$189.72M	-6.95%
2019-06-30	$203.90M	-0.89%
2019-03-31	$205.74M	-5.72%
2018-12-31	$218.22M	9.03%
2018-09-30	$200.15M	-5.50%
2018-06-30	$211.80M	1.38%
2018-03-31	$208.91M	1.47%
2017-12-31	$205.88M	6.44%
2017-09-30	$193.41M	-0.71%
2017-06-30	$194.80M	2.60%
2017-03-31	$189.86M	-0.91%
2016-12-31	$191.60M	1.92%
2016-09-30	$187.99M	-0.64%
2016-06-30	$189.20M	3.13%
2016-03-31	$183.46M	-4.33%
2015-12-31	$191.77M	2.49%
2015-09-30	$187.12M	1.17%
2015-06-30	$184.95M	-1.36%
2015-03-31	$187.50M	-0.63%
2014-12-31	$188.69M	0.66%
2014-09-30	$187.46M	2.06%
2014-06-30	$183.68M	6.01%
2014-03-31	$173.27M	0.30%
2013-12-31	$172.74M	6.48%
2013-09-30	$162.23M	-1.20%
2013-06-30	$164.20M	0.93%
2013-03-31	$162.69M	-0.90%
2012-12-31	$164.16M	1.27%
2012-09-30	$162.10M	6.79%
2009-12-31	$151.80M	11.37%
2009-09-30	$136.30M	-2.01%
2009-06-30	$139.10M	7.83%
2009-03-31	$129.00M	1.02%
2008-12-31	$127.70M	-6.24%
2008-09-30	$136.20M	-4.95%
2008-06-30	$143.30M	8.23%
2008-03-31	$132.40M	7.47%
2007-12-31	$123.20M	9.41%
2007-09-30	$112.60M	-8.31%
2007-06-30	$122.80M	13.28%
2007-03-31	$108.40M	-7.35%
2006-12-31	$117.00M	11.64%
2006-09-30	$104.80M	-0.38%
2006-06-30	$105.20M	4.26%
2006-03-31	$100.90M	1.20%
2005-12-31	$99.70M	7.67%
2005-09-30	$92.60M	-

Phibro Animal Health generated $373.91M in revenue during Q2 2026, up 2.75% compared to the previous quarter, and up 143.57% compared to the same period a year ago.

Phibro Animal Health Revenue Breakdown

Phibro Animal Health Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Jun 26	Jun 25	Jun 24	Jun 23	Jun 22
Vaccines	$156.42M	$137.15M	$120.85M	$100.00M	$88.32M

Phibro Animal Health's latest annual revenue breakdown by segment (product or service), as of Jun 26: Vaccines (100.00%).

Quarterly Revenue by Product

Product/Service	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Mar 22	Dec 21	Sep 21	Jun 21
Vaccines	$40.05M	$38.63M	$37.64M	$40.11M	$38.57M	$33.38M	$33.17M	$32.03M	$31.99M	$32.92M	$29.73M	$26.22M	$26.20M	$22.77M	$23.02M	-	-	-	-	-
Performance Products	-	-	-	-	-	-	-	-	-	-	-	-	$19.85M	$18.32M	$19.20M	$18.02M	$22.00M	$15.13M	$19.23M	$16.74M
Animal Health	-	-	-	-	-	-	-	-	-	-	-	-	$176.75M	$164.43M	$163.80M	$154.86M	$22.86M	$21.87M	$21.25M	$18.73M
Mineral Nutrition	-	-	-	-	-	-	-	-	-	-	-	-	$58.44M	$62.92M	$61.64M	$59.65M	$69.03M	$66.66M	$54.43M	$56.81M

Phibro Animal Health's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Vaccines (100.00%).

Phibro Animal Health Revenue Breakdown by Country

Annual Revenue by Country

Country	Jun 26	Jun 25	Jun 24	Jun 23	Jun 22
UNITED STATES	$877.13M	$739.92M	$584.76M	$578.77M	$561.80M
Asia Pacific	$112.36M	$97.42M	$63.23M	$61.45M	$66.93M
EMEA	$187.94M	$160.23M	$121.98M	$117.81M	$122.48M
Latin America and Canada	$340.67M	$298.65M	$247.71M	$219.85M	$191.05M
Vaccines	-	-	-	-	$88.32M

Phibro Animal Health's latest annual revenue breakdown by geography, as of Jun 26: UNITED STATES (57.78%), Latin America and Canada (22.44%), EMEA (12.38%), and Asia Pacific (7.40%).

Quarterly Revenue by Country

Country	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Mar 22	Dec 21	Sep 21	Jun 21
Asia Pacific	$32.52M	$30.68M	$19.77M	$29.38M	$35.03M	$28.22M	$19.56M	$14.61M	$16.91M	$17.08M	$14.76M	$14.48M	$17.80M	$15.09M	$13.61M	$14.95M	$17.82M	$15.53M	$14.75M	$16.15M
Latin America and Canada	$90.22M	$75.62M	$87.60M	$87.23M	$84.07M	$70.75M	$72.67M	$71.15M	$70.17M	$53.65M	$65.18M	$58.70M	$59.90M	$53.88M	$53.82M	$52.25M	$45.05M	$48.01M	$42.66M	-
UNITED STATES	$220.25M	$232.77M	$221.76M	$202.35M	$201.99M	$209.94M	$184.44M	$143.55M	$153.68M	$159.31M	$140.48M	$131.29M	$145.05M	$148.53M	$149.39M	$135.80M	-	-	-	-
EMEA	$53.75M	$44.47M	$44.78M	$44.94M	$57.61M	$38.91M	$32.59M	$31.13M	$32.41M	$33.17M	$29.52M	$26.88M	$32.30M	$28.17M	$27.83M	$29.52M	-	-	-	-
Animal Health	-	-	-	-	-	-	-	-	-	-	-	-	-	$164.43M	-	-	-	-	-	-
Mineral Nutrition	-	-	-	-	-	-	-	-	-	-	-	-	-	$62.92M	-	-	-	-	-	-
Performance Products	-	-	-	-	-	-	-	-	-	-	-	-	-	$18.32M	-	-	-	-	-	-
Vaccines	-	-	-	-	-	-	-	-	-	-	-	-	-	$26.20M	-	-	-	-	-	-
Europe, Middle East and Africa	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$29.93M	$30.03M	$30.93M	-
United States	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$146.82M	$139.15M	$126.32M	-
Latin America And Canada	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$50.52M
U	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$124.44M
Europe Middle East And Africa	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$29.17M

Phibro Animal Health's latest quarterly revenue breakdown by geography, as of Jun 26: UNITED STATES (55.51%), Latin America and Canada (22.74%), EMEA (13.55%), and Asia Pacific (8.20%).

Phibro Animal Health Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
OGN	Organon	$6.22B	$1.56M
MD	Pediatrix Medical Group	$1.91B	$487.78M
PAHC	Phibro Animal Health	$1.52B	$373.91M
TLRY	Tilray Brands	$915.45M	$206.73M
ANIP	ANI Pharmaceuticals	$883.37M	$266.04M
EVO	Evotec SE	$781.43M	$208.73M
MNKD	MannKind	$348.97M	$109.37M
AUPH	Aurinia Pharmaceuticals	$283.06M	$83.22M
AVDL	Avadel Pharmaceuticals	$169.12M	$77.47M
ALVO	Alvotech	$91.43M	$12.43M
BGM	BGM Group	$25.10M	$12.56M

PAHC Revenue FAQ

What is Phibro Animal Health’s yearly revenue?

Phibro Animal Health's yearly revenue for 2026 was $1.52B, representing an increase of 17.12% compared to 2025. The company's yearly revenue for 2025 was $1.3B, representing an increase of 27.37% compared to 2024. PAHC's yearly revenue for 2024 was $1.02B, representing an increase of 4.07% compared to 2023.

What is Phibro Animal Health’s quarterly revenue?

Phibro Animal Health's quarterly revenue for Q2 2026 was $373.91M, a 2.75% increase from the previous quarter (Q1 2026), and a 20.90% increase year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $363.89M, a -3.91% decrease from the previous quarter (Q4 2025), and a 39.73% increase year-over-year (Q1 2025). PAHC's quarterly revenue for Q4 2025 was $378.7M, a 8.88% increase from the previous quarter (Q3 2025), and a 38.63% increase year-over-year (Q4 2024).

What is Phibro Animal Health’s revenue growth rate?

Phibro Animal Health's revenue growth rate for the last 3 years (2024-2026) was 49.17%, and for the last 5 years (2022-2026) was 61.11%.

What are Phibro Animal Health’s revenue streams?

Phibro Animal Health's revenue streams in n 26 are Vaccines

What is Phibro Animal Health’s main source of revenue?

For the fiscal year ending Jun 26, the largest source of revenue of Phibro Animal Health was Vaccines. This segment made a revenue of $156.42M, representing 100.00% of the company's total revenue.